| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e72837de81999e7e72cb78d59d19e28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe557ffef119de98ac130a7b1c7859b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f50ff908b1e27ef37a145df93b6f4cd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35d9ddd9f56e7f62be5d219a16cc62e4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-174614
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01J49-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-493
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
| filingDate |
2008-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_486cbb3c872603a681cab91275895728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d676d3c7bb788be3a050407352505d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b123e0f526ac76fea1ca68a41a456ed0 |
| publicationDate |
2009-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009073839-A1 |
| titleOfInvention |
Trimethylamine compounds as risk predictors of cardiovascular disease |
| abstract |
Methods of characterizing a test subject's risk of having or developing cardiovascular disease are provided. The methods include using an analytic device to determine levels of choline-related trimethylamine-containing compounds such as trimethylamine N-oxide, choline, or betaine in a biological sample obtained from the subject and comparing the levels of the choline-related trimethylamine-containing compound in the subject's biological sample to a control value. The test subject's risk of having cardiovascular disease is then characterized as higher if the levels of the choline-related trimethylamine-containing compound are higher than the control value. Also provided are methods of identifying a subject at risk of experiencing a complication of atherosclerotic cardiovascular disease, and methods of evaluating the efficacy of a cardiovascular therapeutic agent in a subject with cardiovascular disease using levels of choline-related trimethylamine-containing compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017095975-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9265736-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108472267-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2858517-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012207822-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102827011-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3524235-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111505132-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2435097-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10241093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10064830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10551372-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2435097-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9423405-B2 |
| priorityDate |
2007-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |